Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Acute myeloid leukemias, myelodysplastic syndromes, and myelodysplastic/myeloproliferative neoplasms arising as a result of the mutagenic effect of chemotherapy agents and/or radiation that are used for the treatment of neoplastic or non-neoplastic disorders.
Biomarker and diagnostic research for therapy-related myeloid neoplasm has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include drug therapy and biologic therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
81 publications have been identified in PubMed for therapy-related myeloid neoplasm. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (21%), and Epidemiology / Natural History (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 25 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 9:41 PM UTC
Patient case studies | 16 | 21% |
Disease patterns and progression | 14 | 18% |
Clinical study results | 11 | 14% |
Laboratory research | 6 | 8% |
Other research | 2 | 3% |
Testing and diagnosis research | 2 | 3% |
Hassan F (2026). [PMID: 41897553](https://pubmed.ncbi.nlm.nih.gov/41897553/). *Diagnostics (Basel)*. [Case Report / Case Series]
Thomas J (2026). [PMID: 41953869](https://pubmed.ncbi.nlm.nih.gov/41953869/). *J Med Cases*. [Case Report / Case Series]
Itonaga H (2026). [PMID: 41937388](https://pubmed.ncbi.nlm.nih.gov/41937388/). *Br J Haematol*. [Epidemiology / Natural History]
Palmieri R (2026). [PMID: 41346286](https://pubmed.ncbi.nlm.nih.gov/41346286/). *Blood Adv*. [Epidemiology / Natural History]
Carraway HE (2026). [PMID: 41895012](https://pubmed.ncbi.nlm.nih.gov/41895012/). *Leuk Res*. [Review / Meta-Analysis]
Ganeshalingam V (2026). [PMID: 41978936](https://pubmed.ncbi.nlm.nih.gov/41978936/). *Int J Lab Hematol*. [Case Report / Case Series]
Goldfinger M (2026). [PMID: 41924907](https://pubmed.ncbi.nlm.nih.gov/41924907/). *Haematologica*. [Clinical Trial Publication]
Unknown (2026). [PMID: 41814003](https://pubmed.ncbi.nlm.nih.gov/41814003/). *Nat Genet*. [Epidemiology / Natural History]
Lorentzen L (2026). [PMID: 41749931](https://pubmed.ncbi.nlm.nih.gov/41749931/). *Cancers (Basel)*. [Review / Meta-Analysis]
Attardi E (2026). [PMID: 41785326](https://pubmed.ncbi.nlm.nih.gov/41785326/). *Blood Adv*. [Clinical Trial Publication]